Nu Skin Enterprises, Inc.
NUS
$8.20
-$0.18-2.15%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -11.85% | -12.04% | -11.37% | -9.70% | -9.38% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -11.85% | -12.04% | -11.37% | -9.70% | -9.38% |
| Cost of Revenue | -5.61% | -6.36% | -23.84% | -5.57% | -7.00% |
| Gross Profit | -14.29% | -14.22% | -6.08% | -11.28% | -10.28% |
| SG&A Expenses | -12.90% | -12.27% | -9.33% | -9.11% | -8.85% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.71% | -10.51% | -13.91% | -8.05% | -8.30% |
| Operating Income | -28.28% | -33.03% | 30.53% | -30.33% | -22.56% |
| Income Before Tax | -417.40% | -758.63% | -359.39% | -430.57% | -75.24% |
| Income Tax Expenses | -118.32% | -258.24% | 72.14% | 68.67% | 166.76% |
| Earnings from Continuing Operations | -1,063.13% | -1,805.57% | -276.34% | -311.81% | -104.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,063.13% | -1,805.57% | -276.34% | -311.81% | -104.28% |
| EBIT | -28.28% | -33.03% | 30.53% | -30.33% | -22.56% |
| EBITDA | -21.32% | -21.48% | 21.12% | -20.21% | -14.57% |
| EPS Basic | -1,080.00% | -1,795.46% | -275.43% | -310.33% | -104.23% |
| Normalized Basic EPS | -27.91% | -41.23% | 31.00% | -42.43% | -33.53% |
| EPS Diluted | -1,004.01% | -1,860.20% | -278.35% | -313.80% | -104.73% |
| Normalized Diluted EPS | -27.84% | -40.98% | 32.03% | -42.16% | -33.17% |
| Average Basic Shares Outstanding | 0.07% | -0.10% | -0.27% | -0.37% | -0.46% |
| Average Diluted Shares Outstanding | 0.21% | -0.44% | -0.71% | -0.82% | -0.98% |
| Dividend Per Share | -80.49% | -84.62% | -63.34% | -41.94% | -20.39% |
| Payout Ratio | 0.98% | -1.01% | -1.21% | -1.27% | -19.55% |